跳至主要内容
临床试验/CTRI/2024/11/077387
CTRI/2024/11/077387尚未招募不适用

Evaluating the efficacy of Pre and Probiotics supplementation in Managing Polycystic Ovarian Syndrome

Gupte Hospital and Centre for Research in Reproduction1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年12月2日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. Improvement in insulin resistance.

研究概览

简要总结

Polycystic ovary syndrome (PCOS) affects 3.6% to 15% of women of reproductive age and is linked to issues like infertility, endometrial cancer, obesity, and metabolic diseases. While the exact cause of PCOS is unknown, insulin resistance, altered gonadotropin signaling, and ovarian dysfunction are involved in its development. Recent studies show that women with PCOS have distinct gut microbiota profiles compared to healthy women, with a bidirectional relationship between gut health and PCOS features. Since gut microbiota affects insulin resistance, obesity, and inflammation—key aspects of PCOS—modulating the gut microbiome is being explored as a new treatment approach alongside traditional pharmacological and lifestyle interventions.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
19.00 Year(s) 至 37.00 Year(s)(—)
性别
Female

入选标准

  • Reproductive-aged women (19–37 years) with a confirmed diagnosis of PCOS according to the 2003 Rotterdam criteria and a body mass index (BMI) ≥ 25 kg/m2 were included.

排除标准

  • Subjects with a history of chronic diseases, including diabetes, lung, pancreatic, renal, liver, or cardiovascular disease, thyroid disorders, hyperprolactinemia, Cushing’s syndrome, autoimmune diseases, allergy to probiotic products, use of antibiotics or multivitamin-mineral supplements within the last three months, and following specific diet or physical activity programs.

结局指标

主要结局

1. Improvement in insulin resistance.

时间窗: At baseline and after 12 weeks

2. restoration of hormonal balance, with particular attention to changes in androgen levels (such as testosterone) and the luteinizing hormone (LH) to follicle-stimulating hormone (FSH) ratio, alongside other relevant reproductive hormones

时间窗: At baseline and after 12 weeks

次要结局

  • impact of probiotic supplementation on clinical characteristics (BMI, Hirsutism , Menstrual irregularity)(After 12 weeks)

研究者

发起方
Gupte Hospital and Centre for Research in Reproduction
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Preeti Arora

Research Division of Accurate Diagnostics Pvt. Ltd

研究点 (1)

Loading locations...

相似试验